Pharmacological characteristics of solid-phase von Willebrand factor in human platelets - Wikidata - awgldk - TriplyDB

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

http://www.wikidata.org/entity/Q28190911

about

sameAs

Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets Nanoparticle-induced platelet aggregation and vascular thrombosis Mechanisms of action of proteinase-activated receptor agonists on human platelets CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility.Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis.Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases.

P2860

Q24672897-A3A9CC35-D8B4-4491-806D-B1540A257441 Q28191813-9EBBDC3F-0A67-4941-9D5F-57707037691F Q28192472-899F9DC2-D4EB-48EF-B054-FFF59C884D3A Q39620217-AD36B089-0AF1-4538-BDCB-3DA401CAAE79 Q41065390-1E82145D-889F-4753-B136-F659370A41C9 Q41912198-9AAAB164-FB04-4E52-87BB-49EDAB6ADE3C Q43261615-F11533D9-36EC-4C7D-BA9B-0F61A8A3CEE4

P2860

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

http://www.wikidata.org/entity/Q28190911

description

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2001

@ast

im November 2001 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: November 2001)

@en

vedecký článok (publikovaný 2001-11)

@sk

vědecký článek publikovaný v roce 2001

@cs

wetenschappelijk artikel (gepubliceerd in 2001-11)

@nl

наукова стаття, опублікована в листопаді 2001

@uk

مقالة علمية (نشرت في نوفمبر 2001)

@ar

name

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@ast

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@en

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@nl

type

label

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@ast

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@en

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@nl

prefLabel

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@ast

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@en

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@nl

P1433

Q28190911-42109669-F413-4161-8E14-CF2BF0408666

P1476

Q28190911-512AFFAC-BB47-4E5F-9510-062DD6DFDB28

P2093

Q28190911-2A8B9486-731F-45A5-A40E-EFDDA3C21D6E

Q28190911-864C3C7C-066A-4FBC-8052-27E3B78E1C16

Q28190911-948D9505-4B11-4D05-8ED2-AC607525EA44

Q28190911-9BE96B3E-564C-465D-8B10-039175C6684D

P2860

Q28190911-10156621-0B11-46DA-95A7-A1B7154CFAE9

Q28190911-158183F7-82CD-49BF-BB90-8B8388128C66

Q28190911-2213DAC6-BC2E-4099-9122-E3B67BF1E0AD

Q28190911-38A71FAD-FF07-4597-BE4A-E570148A3B8F

Q28190911-45CD5B37-FF91-492F-A853-ED5D22B17DEF

Q28190911-4787309B-2BF5-4B1D-916D-25646646870D

Q28190911-4DAE05E6-DE7F-4EBA-8079-A845398B7727

Q28190911-516DDF22-3D76-4949-8C38-74D1CB6CC473

Q28190911-9A3D8F29-90FA-4E9F-803A-D80E032E1BEE

Q28190911-9D980802-0D06-4892-BF19-BCCDDF5BC2DC

P304

Q28190911-19992060-57E7-45C2-A2F6-EBC6B68429BE

P31

Q28190911-6F6F882B-3D02-4EE2-8507-E8B3397EA5FC

P356

Q28190911-F690131D-1C0D-4225-8EA4-F4323BEC333F

P407

Q28190911-6CBE89DF-4DE1-4CDE-A050-C9FE0049DD95

P433

Q28190911-B07BB8B6-CB72-404A-AC9F-EAA741D284F5

P478

Q28190911-58702AC6-5DAB-4D9C-BF91-8D141F7E326C

P577

Q28190911-AE232D8C-D258-46E8-BF88-6808A04914BC

P5875

Q28190911-D06D0FA9-4026-4428-B78E-8D15D42D9DAE

P698

Q28190911-7C9F5B3A-7B28-4682-B803-F0D91806707D

P921

Q28190911-0CA7FB08-0BD6-4DE0-B278-A55E80CC7CA3

P932

Q28190911-96EFBEC8-56FC-45F8-9728-45DA055C8247

P356

P1433

British Journal of Pharmacology

P1476

Pharmacological characteristics of solid-phase von Willebrand factor in human platelets

@en

P2093

A Radomski

http://www.w3.org/2001/XMLSchema#string

M W Radomski

http://www.w3.org/2001/XMLSchema#string

M W Stewart

http://www.w3.org/2001/XMLSchema#string

P Jurasz

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide

Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis.

An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia.

Platelet collagen receptors: a new target for inhibition?

Collagen receptor signaling in platelets and megakaryocytes.

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.

Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.

P304

1013-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0704345

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11671415

http://www.w3.org/2001/XMLSchema#string

P698

11682449

http://www.w3.org/2001/XMLSchema#string

P921

P932

1573038

http://www.w3.org/2001/XMLSchema#string